Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06814054

Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induction of General Anesthesia in Geriatric Patients Undergoing Elective Surgery

In this observational study, we will assess cFT by Carotid ultrasound and IVC collapsibility index for prediction of hypotension after induction of general anesthesia in geriatric patients undergoing elective surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of medicine, Tanta university

Tanta, El Gharbyia, 31111, Egypt

Location status: Recruiting

Location contact

tarek Mostafa

CONTACT

[email protected]

020403332033

About this study

Following the onset of general anesthesia, hypotension is frequently observed, and intraoperative hypotension is linked to end organ damage following surgery, including cardiac ischemia and severe renal injury. postoperative end-organ damage depends on the duration and magnitude.

The incidence of hypotension after induction of general anesthesia varies and is influenced by the induction agent, patient characteristics, and the definition of hypotension.

Hypotension was defined by a 30% reduction in the SBP or 20% reduction in the MAP from baseline or an absolute SBP of less than 90 mm Hg and MAP of less than 65 mm Hg within 3 minutes after induction of general anesthesia.

Elderly people are more likely to experience hemodynamic fluctuation and hypotension due to the high prevalence of left ventricular diastolic failure, lower vascular reactivity and higher sensitivity to anesthetics. More significantly, older patients can't tolerate hypotension for a long time.

A variety of hemodynamic monitoring techniques have been used to predict post- anesthetic hypotension. Non-invasive cardiometry, ultrasound evaluation of fluid status, and pulse oximetry variables, such as the perfusion index and pulse variability index, were utilized.

Zhang and Critchley demonstrated that preoperative hypovolemia predicted postinduction hypotension as determined by the inferior vena cava (IVC) diameter and IVC collapsibility index.

In many clinical situations, volume-responsive patients have been identified using Doppler-derived metrics such as the peak blood flow peak velocity variation (ðVpeak) and the common carotid artery corrected flow time (cFT).

The carotid artery Doppler measures provide several benefits, including being noninvasive and being technically simple to obtain due to the carotid artery's superficial nature. Since the common carotid artery cFT is unaffected by respiratory attempts, it can also be used to assess a patient's volume responsiveness when they are breathing on their own.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anaesthesiologists Physical Status I to Ⅱ
  • receiving general anesthesia for elective surgery
  • fasted for at least 6 to 8 hours were recruited in this study

Exclusion criteria

  • • patients who refused to participate in the study
  • American Society of Anaesthesiologists Physical Status Ⅲ or Ⅳ
  • Patients with a history of peripheral arterial diseases or atherosclerosis
  • Patients with body mass index of greater than 30 kg/m2
  • Patients with arrhythmia or cardiomyopathy
  • Chronic obstructive pulmonary disease (COPD)
  • baseline systolic arterial pressure (SAP) ≥ 180 mmHg or < 90mmHg
  • Any episode of desaturation or difficult intubation during general anasethia induction

Treatment and study plan

Carotid Artery Corrected Flow Time measurement

Diagnostic Test
  • The cFT is defined as the time between the onset of systolic flow until closure of the aortic valve corrected for the HR and has been found to correlate with the intravascular volume.
  • carotid ultrasound imaging will be performed 10 minutes before induction of general anesthesia in the preoperative holding area.
  • Ultrasound measurements will be performed under a vascular setting with a 6.0 to 13.0MHz linear array transducer
  • The right common carotid artery cFT will be measured in supine position with their heads tilted 30° to the left
  • After that, a pulse wave Doppler will be chosen, and the sampling frame will be positioned at an angle of less than 60° in the region of the carotid artery with the best color flow to acquire the blood flow spectrum.

Inferior vena cava collapsibility index

Diagnostic Test
  • The IVC will be examined while the patient has been spontaneously, quietly breathing and lying in the supine position for at least 5 min before assessment.
  • A two-dimensional image of the IVC as it entered the right atrium will be obtained through the paramedian long-axis view via a subcostal approach using a curvilinear phased array probe (2-5 MHz)
  • Then, using M-mode imaging produced at a medium sweep speed, changes in IVC diameter with breathing will be evaluated 2 to 3 cm distal to the right atrium.
  • During the same respiratory cycle, measurements will be made of the IVC's greatest expiratory diameter (dIVC expiration) and lowest inspiratory diameter (dIVC inspiration). The formula IVCCI = (dIVC expiration - dIVC inspiration) × 100/dIVC expiration will be used to determine IVCCI as a percentage. (12)
  • IVCCI will be assessed by the same trained anesthesiologist who was blinded to postin duction hemodynamic measurements.

Primary outcomes

  1. the diagnostic efficacy of cFT by Carotid ultrasound and IVC collapsibility index in prediction of hypotension after induction of general anesthesia in geriatric patients

    Time frame: immediate preoperative peroid before the induction of general anesthesia

    the diagnostic efficacy of cFT by Carotid ultrasound and IVC collapsibility index in prediction of hypotension after induction of general anesthesia in geriatric patients undergoing elective surgery.

Study contacts

Contact information is provided by the study sponsor or research team.

sameh Ahmed

CONTACT

[email protected]

tarek AH Mostafa

CONTACT

[email protected]

01003591332

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 7, 2025
Registry last updated
Jul 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.